Literature DB >> 22175885

Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma.

José García-Solano1, Pablo Conesa-Zamora, Javier Trujillo-Santos, Markus J Mäkinen, Miguel Pérez-Guillermo.   

Abstract

AIMS: To assess the incidence of tumour budding (TB), cytoplasmic pseudo-fragments (CyPs), tumour growth pattern (TGP) and peritumoural lymphocytic infiltration (PLI) in a series of serrated adenocarcinoma (SAC) and conventional carcinomas (CCs) of the colorectum in order to ascertain whether such features could explain the worse prognosis of SAC and whether they have prognostic value in SACs. METHODS AND
RESULTS: Tumour budding, CyPs, TGP and PLI were evaluated in 81 SACs and 81 matched CCs. Kaplan-Meier survival curves and Cox logistic regression analysis were obtained for histological parameters. SACs had more high-grade (HG) TB (HG-TB) (69.1%), HG-CyPs (47%), infiltrative TGP (42%) and weak PLI (W-PLI) (65.4%) than CCs (40.7%, P = 0.0003; 19.7%, P = 0.0002; 29.7%, P = 0.07; 45.7%, P = 0.0087). SACs with HG-TB (P = 0.017), HG-CyPs (P = 0.045), infiltrating TGP (P < 0.001) and W-PLI (P = 0.04) had a worse 5-year survival, as had SACs with infiltrating TGP (P = 0.047) and W-PLI (P = 0.04) compared with CCs. For SACs, infiltrative TGP and W-PLI were independent prognostic parameters on multivariate analysis, as was location and regional node status.
CONCLUSION: Compared to CC, SAC displayed more HG-TB, HG-CyPs and fewer PLI at the invasive margins and this may account for its poorer clinical outcome. TB, CyPs, TGP and PLI are useful histological prognostic aids in SAC.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Year:  2011        PMID: 22175885     DOI: 10.1111/j.1365-2559.2011.04043.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  18 in total

1.  Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC.

Authors:  Konrad Steinestel; Jochen K Lennerz; Stefan Eder; Klaus Kraft; Annette Arndt
Journal:  Virchows Arch       Date:  2014-06-12       Impact factor: 4.064

2.  Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma.

Authors:  Takashi Murakami; Hiroyuki Mitomi; Takashi Yao; Tsuyoshi Saito; Tomoyoshi Shibuya; Naoto Sakamoto; Taro Osada; Sumio Watanabe
Journal:  Virchows Arch       Date:  2017-09-19       Impact factor: 4.064

3.  Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells.

Authors:  Silvia Montoro-García; Begoña Alburquerque-González; Ángel Bernabé-García; Manuel Bernabé-García; Priscila Campioni Rodrigues; Helena den-Haan; Irene Luque; Francisco José Nicolás; Horacio Pérez-Sánchez; María Luisa Cayuela; Tuula Salo; Pablo Conesa-Zamora
Journal:  J Mol Med (Berl)       Date:  2020-01-29       Impact factor: 4.599

4.  Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.

Authors:  Daniel L Worthley; Susan L Woods; Tamsin R M Lannagan; Young K Lee; Tongtong Wang; Jatin Roper; Mark L Bettington; Lochlan Fennell; Laura Vrbanac; Lisa Jonavicius; Roshini Somashekar; Krystyna Gieniec; Miao Yang; Jia Q Ng; Nobumi Suzuki; Mari Ichinose; Josephine A Wright; Hiroki Kobayashi; Tracey L Putoczki; Yoku Hayakawa; Simon J Leedham; Helen E Abud; Ömer H Yilmaz; Julie Marker; Sonja Klebe; Pratyaksha Wirapati; Siddhartha Mukherjee; Sabine Tejpar; Barbara A Leggett; Vicki L J Whitehall
Journal:  Gut       Date:  2018-04-17       Impact factor: 23.059

5.  HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer.

Authors:  Anne Tuomisto; José García-Solano; Päivi Sirniö; Juha Väyrynen; Miguel Pérez-Guillermo; Markus J Mäkinen; Pablo Conesa-Zamora
Journal:  Virchows Arch       Date:  2016-07-15       Impact factor: 4.064

6.  Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.

Authors:  José García-Solano; María Eulalia García-Solano; Daniel Torres-Moreno; Pablo Carbonell; Javier Trujillo-Santos; Miguel Pérez-Guillermo; Pablo Conesa-Zamora
Journal:  Cell Oncol (Dordr)       Date:  2016-02-01       Impact factor: 6.730

Review 7.  The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.

Authors:  Viktor H Koelzer; Alessandro Lugli
Journal:  Front Oncol       Date:  2014-02-18       Impact factor: 6.244

8.  BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.

Authors:  Naoya Sakamoto; Ying Feng; Carmine Stolfi; Yuki Kurosu; Maranne Green; Jeffry Lin; Megan E Green; Kazuhiro Sentani; Wataru Yasui; Martin McMahon; Karin M Hardiman; Jason R Spence; Nobukatsu Horita; Joel K Greenson; Rork Kuick; Kathleen R Cho; Eric R Fearon
Journal:  Elife       Date:  2017-01-10       Impact factor: 8.140

9.  Autophagy enhances the aggressiveness of human colorectal cancer cells and their ability to adapt to apoptotic stimulus.

Authors:  Hai-Yang Zheng; Xiao-Yang Zhang; Xing-Fen Wang; Bao-Cun Sun
Journal:  Cancer Biol Med       Date:  2012-06       Impact factor: 4.248

10.  Methylome profiling reveals functions and genes which are differentially methylated in serrated compared to conventional colorectal carcinoma.

Authors:  Pablo Conesa-Zamora; José García-Solano; María Del Carmen Turpin; Patricia Sebastián-León; Daniel Torres-Moreno; Eduardo Estrada; Anne Tuomisto; Jamie Wilce; Markus J Mäkinen; Miguel Pérez-Guillermo; Ana Conesa
Journal:  Clin Epigenetics       Date:  2015-09-17       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.